Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

2 Perfect Stocks For Low-Risk Investors in 2021

By David Jagielski - Dec 27, 2020 at 2:30PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

These companies are in different industries, pay dividends, and their businesses have continued to do well this year despite the coronavirus pandemic.

There's a lot of optimism that the economy and day-to-day life will get back to normal next year now that there are multiple vaccines showing a high rate of efficacy in preventing COVID-19. However, there's no guarantee how things will play out in 2021 and especially given how unpredictable this past year has been, investors may want to stick to low-risk investments that can do well under many different scenarios to keep their portfolios safe.

Two safe stocks you can buy today include Abbott Laboratories ( ABT -0.80% ) and Microsoft ( MSFT -1.51% ). Their businesses have done well over the years, including during the pandemic, and will likely continue doing so for the foreseeable future. Here's why they're optimal buys for risk-averse investors.

Are you diversified written in a notebook.

Image source: Getty Images.

1. Abbott Laboratories

What conservative investors will like about Abbott Laboratories is the company's versatility. The Illinois-based business has booked $23.9 billion in revenue through the first nine months of 2020, and that's 1.3% higher than the $23.6 billion it recorded in the same period last year. Net earnings of $2.3 billion remain strong but are down 11.6% from a year ago.

Although hospitals are deferring procedures to help manage COVID-19, Abbott's business has adapted to that. Sales in its pharmaceutical division are down 4.7% this year and medical device revenue has fallen 5.6%. However, nutritional sales are up 3.1% and Abbott's sales from its diagnostics segment have risen by 14.2%. The company is well-diversified, and that's what makes it a resilient investment to hold in both good times and bad.

One of the ways Abbott has adapted to the pandemic is by developing various COVID-19 tests, including one that costs just $5 and can deliver results in 15 minutes. Most recently, the Food and Drug Administration approved a $25 antigen test from Abbott that people can use at home, which can also produce rapid results. The company estimates that in the first quarter of next year it will ship out 30 million of the tests and another 90 million the following quarter. 

Abbott's in a great position to do well next year, whether or not things go back to normal. Either way, its COVID-19 tests are likely to be in demand as people stay safe. And in a best-case scenario where hospitals resume normal operations, its medical device sales should also get a boost. The healthcare stock also makes for a stable dividend investment, as it is a Dividend Aristocrat that has increased its payouts for 49 years in a row and today yields 1.7% -- just slightly below the S&P 500 average of 1.8%. 

Year to date, the stock is up 24% and is outperforming the index, which has rallied 14%.

2. Microsoft

A good tech stock that you can rely on to do well next year is Microsoft. The Washington-based business is seeing continued demand for its services this year as companies are doing more work remotely and relying on the cloud. Although its revenue from search ads is down over the past two quarters, its cloud business Azure still grew at a rate of more than 40% year over year during that time, and sales from its Office 365 commercial products are still rising at around 20%.

Overall, Microsoft's sales of $37.2 billion in the first quarter of fiscal 2021, for the period ending Sep. 30 (which it released on Oct. 27), grew at a rate of 12% from the prior-year period. That's down slightly from the 13% growth it achieved in the previous quarter. Meanwhile, the company's bottom line continues to be strong, with Microsoft reporting profit margins of at least 29% in each of the past four quarters.

The tech giant's products will be in demand whether people are working from their offices or from their homes next year. And that's what makes Microsoft a safe bet to do well in any scenario in 2021. In the best-case scenario where companies are recovering and spending more money on ads, its search-related revenue should bounce back, and that will give its top line an added boost. 

Although Microsoft isn't a Dividend Aristocrat, it can also be a solid investment that gives you some recurring dividend income to add on top of the capital gains you're likely to earn from owning the stock. Year to date, shares of Microsoft are up over 42% and its dividend yields right around 1% per year. 

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis – even one of our own – helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Abbott Laboratories Stock Quote
Abbott Laboratories
ABT
$127.01 (-0.80%) $-1.02
Microsoft Corporation Stock Quote
Microsoft Corporation
MSFT
$331.53 (-1.51%) $-5.10

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
673%
 
S&P 500 Returns
142%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 11/30/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Our Most Popular Articles

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.